Mind boggling, even at your prior price point. You could even discount to 20% capture rate and it's still crazy. Can this little $130m pharma co that has no idea what its been doing the last 8 years really pull it off.

Key thing to remember also in all this FDA talk, they stated the label is done. So ipso facto once these "corrections"...whatever they are...are shown to be complete it better be a check the box and approve type thing, Class 1.